‘Someday it will be the norm’: physician perspectives on the utility of genome sequencing for patient care in the MedSeqProject

Author:

Vassy Jason L123,Christensen Kurt D34,Slashinski Melody J5,Lautenbach Denise M34,Raghavan Sridharan36,Robinson Jill Oliver7,Blumenthal-Barby Jennifer7,Feuerman Lindsay Zausmer7,Lehmann Lisa Soleymani236,Murray Michael F8,Green Robert C34,McGuire Amy L7

Affiliation:

1. Section of General Internal Medicine, VA Boston Healthcare System, Boston, MA 02130, USA

2. Division of General Medicine & Primary Care, Department of Medicine, Brigham & Women's Hospital, Boston, MA 02115, USA

3. Department of Medicine, Harvard Medical School, Boston, MA 02115, USA

4. Division of Genetics, Brigham & Women's Hospital, Boston, MA 02115, USA

5. School of Public Health & Health Sciences, University of Massachusetts, Amherst, MA 01003, USA

6. General Medicine Division, Massachusetts General Hospital, Boston, MA 02114, USA

7. Center for Medical Ethics & Health Policy, Baylor College of Medicine, Houston, TX 77030, USA

8. Geisinger Health System, Danville, PA 17822 4910, USA

Abstract

Aim: To describe practicing physicians’ perceived clinical utility of genome sequencing. Materials & methods: We conducted a mixed-methods analysis of data from 18 primary care physicians and cardiologists in a study of the clinical integration of whole-genome sequencing. Physicians underwent brief genomics continuing medical education before completing surveys and semi-structured interviews. Results: Physicians described sequencing as currently lacking clinical utility because of its uncertain interpretation and limited impact on clinical decision-making, but they expressed the idea that its clinical integration was inevitable. Potential clinical uses for sequencing included complementing other clinical information, risk stratification, motivating patient behavior change and pharmacogenetics. Conclusion: Physicians given genomics continuing medical education use the language of both evidence-based and personalized medicine in describing the utility of genome-wide testing in patient care.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3